Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-042719
Filing Date
2024-10-28
Accepted
2024-10-28 17:16:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 13428
2 formdefa14a_001.jpg GRAPHIC 1523264
  Complete submission text file 0001493152-24-042719.txt   2110602
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41245 | Film No.: 241401861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)